Active Ingredient: Dexlansoprazole Erosive esophagitis: Healing of all grades of erosive esophagitis in patients ≥12 years of age for up to 8 weeks; to maintain healing of erosive esophagitis and relief of heartburn for up to 6 months in adults and 16 weeks in patients 12 to 17 years of age.
Gastroesophageal reflux disease: Treatment of heartburn associated with symptomatic nonerosive gastroesophageal reflux disease (GERD) in patients ≥12 years of age for 4 weeks.